|
Mumbai: Shasun Chemicals & Drugs Ltd has announced that it is setting up a process development facility in Piscataway (New Jersey), U.S. The facility will be scaled to provide direct Active Pharmaceutical Ingredients (API's) development services in the p re-clinical and clinical trial stages to customers in North America and to extend backend support to the CRAMS partners there.
The first phase new facility will be operational from April 2008 and represents significant investment in terms of both long-term financial commitment.
Commenting on the development, Kevin Cook, Director (Operations), Shasun Pharma Solutions UK said; "The US facility will allow us to provide North American customers with a local service offering to compliment our existing sites in Europe and India."
Quarterly results of corporates: Check out
Dr. Michel Spagnol, Chief Technology Officer of Shasun said, "The development will also enhance our position as the leading chemistry services provider with both eastern and western facilities."